Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment complete in pediatric Xerecept trial

Oct. 5, 2011

Novel pan-Aurora kinase inhibitor is active against drug-resistant cancer cells

Oct. 5, 2011

Novel SMYD2 inhibitor identified at AstraZeneca

Oct. 5, 2011

Update on Adventrx's NDA for Exelbine

Oct. 4, 2011

Array BioPharma reports results from selumetinib NSCLC study

Oct. 4, 2011

New TTK inhibitors synthesized by Bayer Schering Pharma

Oct. 4, 2011

Threshold Pharmaceuticals begins pivotal study of TH-302

Oct. 4, 2011

Vernalis and Servier reach milestone in oncology collaboration

Oct. 4, 2011

Kancera products show activity against pancreatic cancer cells

Oct. 4, 2011

Children's Oncology Group and Apeiron to collaborate on phase II study in neuroblastoma

Oct. 3, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...